Why IRADIMED CORPORATION’s (IRMD) Stock Is Up 7.58%
As of Wednesday, November 04, IRADIMED CORPORATION’s IRMD share price has surged by 7.58%, which has investors questioning if this is right time to sell.Rosalio Madrigal
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
Tudor Pop
Tudor Pop
Jenna Brashear
| Share Statistics | IRMD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,039.2 | $356.4 | 47% |
|
| Shares Out (Mil) | 12.9 | 41.2 | 24% |
|
| Institutional Ownership | 64.3% | 83.1% | 40% |
|
| Float (Mil) | 8.3 | 36.7 | 17% |
|
| Beta | 0.94 | 0.89 | 55% |
|
| Avg Daily Volume (000s) | 108 | 318 | 37% |
|
| Price Change (52-week) |
(5.7%) | 55.9% | 47% |
|
| Growth | IRMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 21.5% | 11.8% | 83% |
|
| Net Income (5yr) | 74.3% | (5.8%) | 97% |
|
| EPS (5yr) | 73.9% | 10.6% | 98 |
|
| Dividends (5yr) | 0.0% | 0.0% | 75% |
|
| Cash Flow (5yr) | (16.5%) | (15.6%) | 43% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | $0.593 | $2.097 | $2.437 | |
| Month Ago EPS | $0.630 | $2.113 | $2.453 | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 0 | 1 | 0 | |
| Three Months Ago EPS | $0.615 | $2.090 | $2.410 | |
| Year/Year Chg | 16.5% | 19.8% | 52.9% | |
| Financials | IRMD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $89 | $123 | 25% |
|
| Net Income (TTM) (Mil) | $24 | ($9) | 49% |
|
| EPS (TTM) | $1.878 | ($0.300) | 69% |
|
| Operating Cash Flow (TTM) (Mil) | $27 | ($1) | 42% |
|
| Net Cash Flow (TTM) (Mil) | $7 | $2 | 56% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $21 | 0% |
|
| Enterprise Value (Q1) (Mil) | $1,070 | $381 | 42% |
|
| Valuation | IRMD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 9.77 | 2.46 | 92% |
|
| P/E | 43.5 | 25.5 | 85% |
|
| Dividend Yield | 1.0% | 0.0% | 66% |
|
| PEG (5yr hist) | 0.6 | 1.3 | 31% |
|
| Ratios | IRMD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 75.5% | 59.1% | 86% |
|
| Net Margin | 26.8% | (4.6%) | 85% |
|
| ROA | 20.3% | (9.9%) | 96% |
|
| ROE | 23.4% | (8.5%) | 83% |
|
| Liabilities to Assets | 12.1% | 45.6% | 7% |
|
| F-Score | 5 | 4 | 50% |
|
Passing Stock Screens
As of 11/19/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 12.1% |
| +/- S&P 500: | +4.7 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors